
Orchid Pharma Ltd
NSE:ORCHPHARMA

Cash Flow Statement
Cash Flow Statement
Orchid Pharma Ltd
Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | ||
---|---|---|---|---|---|---|---|
Operating Cash Flow | |||||||
Net Income |
(20)
|
(409)
|
463
|
959
|
890
|
1 163
|
|
Depreciation & Amortization |
870
|
862
|
548
|
309
|
332
|
348
|
|
Other Non-Cash Items |
(503)
|
355
|
(34)
|
(126)
|
107
|
(27)
|
|
Cash Taxes Paid |
19
|
10
|
3
|
(7)
|
(6)
|
2
|
|
Cash Interest Paid |
320
|
387
|
322
|
188
|
164
|
81
|
|
Change in Working Capital |
577
|
(28)
|
(794)
|
(99)
|
(72)
|
(1 343)
|
|
Cash from Operating Activities |
925
N/A
|
782
-15%
|
183
-77%
|
1 043
+469%
|
1 258
+21%
|
141
-89%
|
|
Investing Cash Flow | |||||||
Capital Expenditures |
(144)
|
(706)
|
(849)
|
(498)
|
(648)
|
(823)
|
|
Other Items |
1 273
|
21
|
537
|
(1 991)
|
(2 472)
|
392
|
|
Cash from Investing Activities |
1 129
N/A
|
(686)
N/A
|
(312)
+54%
|
(2 489)
-697%
|
(3 120)
-25%
|
(431)
+86%
|
|
Financing Cash Flow | |||||||
Net Issuance of Common Stock |
0
|
0
|
0
|
3 919
|
3 919
|
0
|
|
Net Issuance of Debt |
(1 848)
|
217
|
634
|
(1 928)
|
(2 085)
|
5
|
|
Other |
(320)
|
(387)
|
(322)
|
(188)
|
(164)
|
(81)
|
|
Cash from Financing Activities |
(2 168)
N/A
|
(169)
+92%
|
312
N/A
|
1 803
+479%
|
1 670
-7%
|
(76)
N/A
|
|
Change in Cash | |||||||
Net Change in Cash |
(114)
N/A
|
(73)
+36%
|
183
N/A
|
358
+96%
|
(192)
N/A
|
(367)
-91%
|
|
Free Cash Flow | |||||||
Free Cash Flow |
781
N/A
|
75
-90%
|
(666)
N/A
|
546
N/A
|
610
+12%
|
(682)
N/A
|